Details of Drug

Drug General Information (ID: D1686)
Drug Name	Velpatasvir
Drug Type	Small molecule
Disease Class	1E50-1E51: Hepatitis virus infection
Therapeutic Class	Antiviral Agents
Structure
Structure	3D Structure		2D Structure
Formula	C49H54N8O8
InChI	1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1
InChIKey	FHCUMDQMBHQXKK-CDIODLITSA-N
Canonical SMILES	CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC
External Link
	Pubchem ID	67683363
	CAS Number	1377049-84-7
	CHEBI ID	133009
	TTD ID	D09KTI
	INTEDE ID	DR1676
	VARIDT ID	DR01314

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM007 Pharmacodynamic antagonistic effects BM005 Altered gastric pH BM010 Transporter inhibition BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM085 Antagonize the effect of antithrombotic agents
Relation Graph

Full list of drugs interacting with Velpatasvir
Affected gastrointestinal absorption
	Altered gastric pH					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0458		Dexlansoprazole	C16H14F3N3O2S	9578005	Major		Inter Info	[1], [2]
D0603		Esomeprazole	C17H19N3O3S	9568614	Major		Inter Info	[1], [2]
D0892		Lansoprazole	C16H14F3N3O2S	3883	Major		Inter Info	[1], [2]
D1179		Omeprazole	C17H19N3O3S	4594	Major		Inter Info	[1], [2]
D1222		Pantoprazole	C16H15F2N3O4S	4679	Major		Inter Info	[1], [2]
D1373		Rabeprazole	C18H21N3O3S	5029	Major		Inter Info	[1], [2]
D0049		Aluminum hydroxide	AlH3O3	10176082	Moderate		Inter Info	[2]
D0236		Calcium carbonate	CCaO3	10112	Moderate		Inter Info	[2]
D0337		Cimetidine	C10H16N6S	2756	Moderate		Inter Info	[2]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[2]
D0967		Magaldrate	AlHMgO5S+2	3086011	Moderate		Inter Info	[2]
D0968		Magnesium carbonate	CMgO3	11029	Moderate		Inter Info	[2]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[2]
D0974		Magnesium oxide	MgO	14792	Moderate		Inter Info	[2]
D1151		Nizatidine	C12H21N5O2S2	3033637	Moderate		Inter Info	[2]
D1381		Ranitidine	C13H22N4O3S	3001055	Moderate		Inter Info	[2]
D1382		Ranitidine (bismuth citrate)	C13H22N4O3S	3001055	Moderate		Inter Info	[2]
D1480		Sodium bicarbonate	CHNaO3	516892	Moderate		Inter Info	[2]
D1483		Sodium citrate	C6H5Na3O7	6224	Moderate		Inter Info	[2]
Affected cellular transport
	Transporter inhibition					Drug Num: 34
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0380		Colchicine	C22H25NO6	6167	Major		Inter Info	[4], [5], [6]
D0551		Edoxaban	C24H30ClN7O4S	10280735	Major		Inter Info	[1], [7], [8]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Major		Inter Info	[2]
D0171		Berotralstat	C30H26F4N6O	137528262	Major		Inter Info	[9], [10], [11]
D1388		Relugolix	C29H27F2N7O5S	10348973	Major		Inter Info	[12], [13]
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[14], [1], [16]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[1], [17]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[1], [2], [18]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[1], [19]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[20], [21]
D0376		Cobimetinib	C21H21F3IN3O2	16222096	Moderate		Inter Info	[1], [22]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[23], [24], [25]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[23], [24], [25]
D0491		Digoxin	C41H64O14	2724385	Moderate		Inter Info	[28], [29], [2]
D0629		Everolimus	C53H83NO14	6442177	Moderate		Inter Info	[30]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[23], [24], [25]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[27], [31]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[1], [2], [18]
D0980		Maraviroc	C29H41F2N5O	3002977	Moderate		Inter Info	[32]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[1], [2], [18]
D1610		Topotecan	C23H23N3O5	60700	Moderate		Inter Info	[2]
D0176		Betrixaban	C23H22ClN5O3	10275777	Moderate		Inter Info	[37]
D0182		Binimetinib	C17H15BrF2N4O3	10288191	Moderate		Inter Info	[33], [1], [38]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[1], [40]
D0963		Lusutrombopag	C29H32Cl2N2O5S	49843517	Moderate		Inter Info	[34]
D1101		Naldemedine	C32H34N4O6	54732242	Moderate		Inter Info	[1], [46]
D1396		Revefenacin	C35H43N5O4	11753673	Moderate		Inter Info	[47], [48], [49]
D1409		Ripretinib	C24H21BrFN5O2	71584930	Moderate		Inter Info	[33], [53]
D1532		Talazoparib	C19H14F2N6O	135565082	Moderate		Inter Info	[55]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Moderate		Inter Info	[21], [57]
D1710		Voxilaprevir	C40H52F4N6O9S	89921642	Moderate		Inter Info	[58]
D0658		Fidaxomicin	C52H74Cl2O18	10034073	Minor		Inter Info	[33], [1], [60]
D0797		Indacaterol	C24H28N2O3	6918554	Minor		Inter Info	[61]
D1104		Naloxegol	C34H53NO11	56959087	Minor		Inter Info	[62]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[14], [1], [15]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[36]
D0899		Lefamulin	C28H45NO5S	25185057	Moderate		Inter Info	[41], [42], [43]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[45]
D1398		Ribociclib	C23H30N8O	44631912	Moderate		Inter Info	[50], [51], [52]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[34]
D1459		Selpercatinib	C29H31N7O3	134436906	Moderate		Inter Info	[54]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Moderate		Inter Info	[33], [1], [59]
	CYP450 enzyme induction					Drug Num: 18
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0194		Bosentan	C27H29N5O6S	104865	Major		Inter Info	[1], [2], [3]
D0300		Cenobamate	C10H10ClN5O2	11962412	Major		Inter Info	[1], [2], [3]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Major		Inter Info	[1], [2], [3]
D0453		Dexamethasone	C22H29FO5	5743	Major		Inter Info	[1], [2], [3]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[1], [2], [3]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Major		Inter Info	[1], [2], [3]
D0628		Etravirine	C20H15BrN6O	193962	Major		Inter Info	[1], [2], [3]
D1078		Mitotane	C14H10Cl4	4211	Major		Inter Info	[1], [2], [3]
D1099		Nafcillin	C21H22N2O5S	8982	Major		Inter Info	[1], [2], [3]
D1128		Nevirapine	C15H14N4O	4463	Major		Inter Info	[1], [2], [3]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[1], [2], [3]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[33], [1], [34]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[33], [1], [35]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[33], [1], [35]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[33], [39]
D0901		Lemborexant	C22H20F2N4O2	56944144	Moderate		Inter Info	[44]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[33], [1], [35]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Moderate		Inter Info	[1], [56]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antithrombotic agents					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0481		Dicoumarol	C19H12O6	54676038	Moderate		Inter Info	[1], [26], [27]

References
1	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2	Product Information. Epclusa (sofosbuvir-velpatasvir). Gilead Sciences, Foster City, CA.
3	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
4	Garrouste C, Philipponnet C, Kaysi S, Enache I, Tiple A, Heng AE "Severe colchicine intoxication in a renal transplant recipient on cyclosporine." Transplant Proc 44 (2012): 2851-2. [PMID: 23146540]
5	Jonsson J, Gelpi JR, Light JA, Aquino A, Maszaros S "Colchicine-induced myoneuropathy in a renal transplant patient." Transplantation 53 (1992): 1369-71. [PMID: 1604496]
6	Kuncl RW, Duncan G, Watson D, et al "Colchicine myopathy and neuropathy." N Engl J Med 316 (1987): 1562-8. [PMID: 3035372]
7	Mendell J, Zahir H, Matsushima N, et al. "Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor." Am J Cardiovasc Drugs (2013):. [PMID: 23784266]
8	Product Information. Savaysa (edoxaban). Daiichi Sankyo, Inc., Parsippany, NJ.
9	Ace LN, Jaffe JM, Kunka RL "Effect of food and an antacid on quinidine bioavailability." Biopharm Drug Dispos 4 (1983): 183-90. [PMID: 6882885]
10	Min DI, Ku YM, Geraets DR, Lee HC "Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers." J Clin Pharmacol 36 (1996): 469-76. [PMID: 8739026]
11	Product Information. Orladeyo (berotralstat). BioCryst Pharmaceuticals Inc, Durham, NC.
12	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
13	Product Information. Orgovyx (relugolix). Myovant Sciences, Inc., Brisbane, CA.
14	Canadian Pharmacists Association.
15	Product Information. Zytiga (abiraterone). Centocor Inc, Malvern, PA.
16	Tapaninen T, Backman JT, Kurkinen K, Neuvonen P, Niemi M "Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren." J Clin Pharmacol 51 (2011): 359-67. [PMID: 20400651]
17	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
18	Richter WO, Jacob BG, Schwandt P "Interaction between fibre and lovastatin." Lancet 338 (1991): 706. [PMID: 1679514]
19	Product Information. Bosulif (bosutinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
20	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
21	Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
22	Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
23	Multum Information Services, Inc. Expert Review Panel.
24	Product Information. Daunoxome (daunorubicin liposomal). Nexstar Pharmaceuticals Inc, Boulder, CO.
25	Product Information. Idamycin (idarubicin). Pharmacia and Upjohn, Kalamazoo, MI.
26	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
27	Product Information. Incivek (telaprevir). Vertex Pharmaceuticals, Cambridge, MA.
28	Becquemont L, Verstuyft C, Kerb R, et al. "Effect of grapefruit juice on digoxin pharmacokinetics in humans." Clin Pharmacol Ther 70 (2001): 311-6. [PMID: 11673746]
29	Darcy PF "Nutrient-drug interactions." Adverse Drug React Toxicol Rev 14 (1995): 233-54. [PMID: 8845456]
30	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
31	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
32	Product Information. Selzentry (maraviroc). Pfizer U.S. Pharmaceuticals Group, New York, NY.
33	Cerner Multum, Inc. "Australian Product Information.".
34	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
35	Product Information. Zorbtive (somatropin). Serono Laboratories Inc, Rockland, MA.
36	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
37	Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
38	Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
39	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
40	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
41	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
42	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
43	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
44	Product Information. Dayvigo (lemborexant). Eisai Inc, Woodcliff Lake, NJ.
45	Product Information. Prevymis (letermovir). Merck &amp Company Inc, Whitehouse Station, NJ.
46	Product Information. Symproic (naldemedine). Shionogi USA Inc, Florham Park, NJ.
47	Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
48	Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
49	Product Information. Yupelri (revefenacin). Mylan Specialty, Morgantown, WV.
50	Kane GC, Lipsky JJ "Drug-grapefruit juice interactions." Mayo Clin Proc 75 (2000): 933-42. [PMID: 10994829]
51	Rawden HC, Kokwaro GO, Ward SA, Edwards G "Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes." Br J Clin Pharmacol 49 (2000): 313-22. [PMID: 10759686]
52	Trivier JM, Libersa C, Belloc C, Lhermitte M "Amiodarone N-deethylation in human liver microsomes: involvement of cytochrome P450 3A enzymes (first report)." Life Sci 52 (1993): pl91-6. [PMID: 8445979]
53	Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
54	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
55	Product Information. Talzenna (talazoparib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
56	Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
57	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
58	Product Information. Vosevi (sofosbuvir/velpatasvir/voxilaprevir). Gilead Sciences, Foster City, CA.
59	Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
60	Product Information. Dificid (fidaxomicin). Optimer Pharmaceuticals, San Diego, CA.
61	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
62	Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence